Mark Roskey
Company: Quanterix
Job title: Chief Scientific and Collaboration Officer
Seminars:
Translational Simoa Sensitivity Blood-Based Biomarkers for Neurological Drug Development & Clinical Trial Support 1:45 pm
New high-sensitivity blood-based assays for optimal detection of a wide range of neurodegeneration conditions Specific examples of clinical trial utility of Simoa biomarkers for NfL, N4PE, GFAP, and pTau 181 and pTau217 The translational impact of blood-based biomarkers with Simoa sensitivity for Multiple Sclerosis, and Alzheimer's Disease detection and monitoringRead more
day: Conference Day One